An interventional study of Conventional Exercise Program and Proprioceptive Neuromuscular Facilitation Exercises in Sarcopenia, sponsored by Uşak University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Uşak University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 131 studies in Sarcopenia with a site in Turkey — 36 open to participants now, 43 under way, none of them phase 3. Sarcopenia · Turkey.
Among the 131 studies in Sarcopenia with a site in Turkey, this one is the 15th largest by enrollment of the 34 interventional ones that give a count, is one of 16 that started in 2022, is one of 32 with no phase, and was the 116th registered.
1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.
Browse Sarcopenia studies →36 of the 131 studies in Sarcopenia with a site in Turkey are open now. Recruiting first, the newest first:
Marmara University · Sites in Turkey
Ages 50–75
Izmir Democracy University · Sites in Turkey
Ages 6–18 · Healthy volunteers
Tarsus University · Sites in Turkey
Ages 65–80
Van Training and Research Hospital · Sites in Turkey
Ages 60+
Istanbul Saglik Bilimleri University · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.
This study: 65 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
131 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 16 started in 2022.
This study's enrollment of 40 is below the median of 60 across 860 interventional studies indexed under Sarcopenia.
Median enrollment 40 across the 34 interventional studies, 100 across the 97 observational. Of the 76 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 131 have an industry lead sponsor. The 10 most frequent:
Uşak University is the lead sponsor of 80 studies on the registry; 10 are open to participants now.
Uşak University has 1 study filed under Sarcopenia — fewer than ten, so there is no comparison to draw.
18 of the studies in Sarcopenia with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07813702MERT UYSALURINARY INCONTINENCE AND GERIATRIC SYNDROMES | 2026-11 |
| NCT07858864Istanbul Saglik Bilimleri UniversityGLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes | 2026-11-30 |
| NCT07842731Atılım UniversityInvestigation of the Prevalence of Sarcopenia and Dynapenia According to Disease Stage in Patients With Multiple Sclerosis and Evaluation of the Relationship Between Sarcopenia Severity and Clinical and Functional Parameters | 2026-12-10 |
| NCT06749340Bahçeşehir UniversityExamining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis | 2026-12-23 |
| NCT07357662Tarsus UniversityEffects of Rehabilitative Exergame Training on Foot Muscle Activity, Balance, and Mobility in Older Adults | 2026-12-30 |
Add all 18 to your calendar (.ics) → With an account.
Among the 131 studies in Sarcopenia with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Age-related declines in muscle strength and physical performance may impair balance, mobility, and independence in older adults. Exercise may help preserve these functions; however, thethe comparative benefits of PNF-based exercise versus conventional exercise remain unclear in older women who screen positive for sarcopenia risk.
This randomized study compared a PNF-based exercise program with conventional exercise in community-dwelling women aged 65 years or older with SARC-F scores of 4 or higher. Although all participants screened positive for sarcopenia risk, none met the criteria for confirmed sarcopenia according to the revised European Working Group on Sarcopenia in Older People framework (EWGSOP2). Forty participants were randomly allocated to two groups, with 20 participants in each group. Thirty-four participants completed the study and were included in the analysis, with 17 participants in each group.
Both groups followed a 10-week exercise program comprising three sessions per week, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. The remaining sessions were performed independently at home, with adherence monitored through weekly telephone follow-up.
The conventional exercise program included lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The PNF-based program incorporated diagonal and multiplanar movement patterns and task-oriented functional movements into conventional therapeutic exercises. Manual contacts, manual resistance, and hands-on facilitation were used only during the first three supervised sessions.
Participants were assessed at baseline and at one and three months after completion of the 10-week program. Outcomes included balance, functional mobility, walking capacity, lower-extremity functional strength, stair performance, falls efficacy, and depressive symptoms. Assessments included the Berg Balance Scale, Timed Up and Go Test, 6-Minute Walk Test, Five Times Sit-to-Stand Test, stair ascent and descent test, Tinetti Falls Efficacy Scale, and 15-item Geriatric Depression Scale.
Age-related declines in muscle strength and physical performance may contribute to impaired balance, mobility limitations, and reduced independence. A positive sarcopenia screening result does not establish a diagnosis of sarcopenia. This study focused on community-dwelling older women who screened positive for sarcopenia risk using the SARC-F questionnaire but did not meet EWGSOP2 criteria for confirmed sarcopenia.
The rationale for the study was to investigate whether incorporating proprioceptive neuromuscular facilitation (PNF) principles into a predominantly home-based exercise program provides additional functional benefits compared with conventional therapeutic exercise of comparable duration and frequency.
This prospective, single-center, two-arm randomized study was conducted at the outpatient Physical Medicine and Rehabilitation and Medical Ecology and Hydroclimatology Clinic of Uşak Training and Research Hospital, Uşak, Türkiye. Participants were women aged 65 years or older with SARC-F scores of 4 or higher who could safely participate in the prescribed exercise program. Participants were randomly allocated in a 1:1 ratio using a computer-generated random-number table.
Both groups followed a 10-week program consisting of three approximately 45-minute sessions per week. The first three sessions were supervised by a physiotherapist at the clinic to demonstrate the exercises, correct performance, and prepare participants for independent practice. Subsequent sessions were performed at home, with weekly telephone follow-up to monitor adherence and address participants' questions. Exercise intensity and progression were individualized according to functional capacity and clinical tolerance.
The PNF-based program incorporated diagonal and multiplanar movement patterns, coordinated neuromuscular activation, and task-oriented functional movements into conventional therapeutic exercises. Manual contacts, manual resistance, and hands-on facilitation were restricted to the first three supervised clinic sessions. Home sessions used PNF-derived movement patterns that participants could perform independently.
Participants and treating physiotherapists could not be blinded because of the nature of the interventions. Outcome assessments were performed by a physician who was not involved in delivering the exercise programs.
Assessments were conducted before the intervention and at one and three months after completion of the 10-week program to examine functional changes and their persistence beyond the intervention period. Outcomes covered balance, functional mobility, walking capacity, sit-to-stand and stair performance, falls efficacy, and depressive symptoms.
Forty participants were randomized, and 34 completed the study. Analyses included participants with complete data, without imputation of missing follow-up measurements. The trial was retrospectively registered, and between-group outcome analyses were interpreted as exploratory.
The criteria were revised on the registry on Oct 6, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group received a conventional exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The program comprised three sessions per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. The remaining sessions were performed independently at home, with adherence monitored through weekly telephone follow-up. Exercise intensity and progression were individualized according to each participant's functional capacity and clinical tolerance.
Behavioral: Conventional Exercise Program
Participants in this group received a proprioceptive neuromuscular facilitation (PNF)-based exercise program. The program emphasized diagonal and multiplanar movement patterns, coordinated neuromuscular activation, and task-oriented functional movements targeting postural control, balance, gait, and lower-extremity performance. The program comprised three sessions per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. Manual contacts, manual resistance, and hands-on facilitation techniques were applied only during these supervised sessions. The remaining sessions were performed independently at home using PNF-derived movement patterns taught at the clinic. Adherence was monitored through weekly telephone follow-up. Progression was individualized according to functional improvement.
Behavioral: Proprioceptive Neuromuscular Facilitation Exercises
Participants received a conventional therapeutic exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The program comprised three sessions per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. The remaining sessions were performed independently at home, with adherence monitored through weekly telephone follow-up. Exercise intensity and progression were individualized according to each participant's functional capacity and clinical tolerance.
Participants received proprioceptive neuromuscular facilitation exercises program. The PNF intervention included diagonal movement patterns, proprioceptive stimulation, coordinated neuromuscular activation, manual resistance, and task-oriented functional movement patterns designed to improve postural control, balance, gait, and lower-extremity functional performance. The program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes.Manual contacts, manual resistance, and hands-on facilitation techniques were applied only during the first three supervised clinic sessions. The remaining sessions were performed independently at home using PNF-derived movement patterns taught at the clinic. Adherence was monitored through weekly telephone follow-up.
Also known as: PNF Exercises
Change in Berg Balance Scale score
Balance function was assessed using the Berg Balance Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Changes over time and differences between the groups were analyzed.
Time frame: Baseline and 1 and 3 months after completion of the 10-week exercise programm
Change in Tinetti Falls Efficacy Scale score
Description: Fear of falling was assessed using the Tinetti Falls Efficacy Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Changes over time and differences between the groups were analyzed.
Time frame: Baseline, 1 month, and 3 months after completion of the 10-week exercise programme
Change in Timed Up and Go Test performance
Description: Functional mobility and dynamic balance were assessed using the Timed Up and Go Test. Completion time were measured at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Changes over time and differences between the groups were analyzed. Lower completion times indicated better functional mobility. Changes over time and differences between the groups were analyzed.
Time frame: Baseline and 1 and 3 months completion of the 10-week exercise programme
Change in 6-Minute Walk Test distance
Description: Walking capacity was assessed using the 6-Minute Walk Test. Walking distance, measured in meters, was recorded at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Greater distances indicated better walking capacity. Changes over time and differences between the groups were analyzed.
Time frame: recorded at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme.
Change in Five Times Sit-to-Stand Test time
Description: Lower-extremity functional performance was assessed using the Five Times Sit-to-Stand Test. Completion time, measured in seconds, was recorded at baseline, at the first-month assessment, and at the third-month assessment after t the third-month assessment after completion of the 10-week exercise programme. Lower completion times indicated better functional performance. Changes over time and differences between the groups were analyzed.
Time frame: Time Frame: Baseline, 1 month, and 3 months after initiation of the 10-week exercise programme.
Change in stair ascent and descent test time
Description: Functional stair performance was assessed using a stair ascent and descent test. Completion time, measured in seconds, was recorded at baseline, at the first-month assessment, and at the third-month assessment after the 10-week exercise programme. Lower completion times indicated better stair performance. Changes over time and differences between the groups were analyzed.
Time frame: Time Frame: Baseline, 1 month, and 3 months after the third-month of the 10-week exercise programme.
Change in Geriatric Depression Scale score
Description: Depressive symptoms were assessed using the Geriatric Depression Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessmen the third-month assessment after completion of the 10-week exercise programme. Lower scores indicated fewer depressive symptoms. Changes over time and differences between the groups were analyzed.
Time frame: Baseline, 1 month, and 3 months after completion of the 10-week exercise programme
Plan to share: No — Individual participant data will not be shared because the ethics approval and informed consent documents did not include permission for external sharing of individual-level data. Aggregate study results may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethical regulations.
Ran from Aug 2022 to primary completion in May 2023, 9 months.
Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's 9 months is below that.
Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Feb 2022 → Aug 2022, primary completion Jul 2022 → May 2023 and completion Aug 2022 → Aug 2023.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uşak University